This compound is a pharmaceutical intermediate used in the manufacturing process of ledipasvir, an active pharmaceutical ingredient. It features a complex bicyclic structure with a boronic ester group.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1256387-87-7
Ledipasvir Intermediate
Pharmaceutical intermediate for ledipasvir
(1R,3S,4S)-2-(tert-butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
Pharmaceutical intermediate for ledipasvir
(S)-Benzyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate
Ledipasvir intermediate
Carbamic acid, N-[(1S)-1-[[(6S)-6-[5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]-, methyl ester
Pharmaceutical intermediate
2-methyl-2-(4-vinylphenyl)propanoic acid
Pharmaceutical intermediate
2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid
Pharmaceutical intermediate
tert-butyl (1R,3S,4S)-3-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylate
MYPUONINDNZBTH-GMBSWORKSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC3=C(C=C2)N=C(N3)[C@@H]4[C@H]5CC[C@H](C5)N4C(=O)OC(C)(C)C
—